Home
NewsNewsProtein injection repairs aged eggs by restoring chromosome stability, helping improve IVF success rates for older mothers, according to new fertility research that offers a promising clinical advancement for reproductive health.
A laboratory technique showing that protein injection repairs aged eggs may offer a new way to improve IVF outcomes for older women, according to findings shared by researchers in Europe.
The work was carried out by a research team led by Dr. Melina Schuh at the Max Planck Institute for Multidisciplinary Sciences in Germany. Dr. Melina Schuh, who is also a co-founder of Ovo Labs, presented the data at the British Fertility Society Conference in Scotland. The study was released simultaneously on the preprint platform bioRxiv.
Fertility decreases rapidly with age because eggs created before birth have to lie dormant for years before being ovulated. While IVF is still moderately effective for women under age 35, success rates plummet after age 40 because eggs fail to evenly divide their chromosomes during meiosis. Mistakes during meiosis can lead to embryos with missing or extra chromosomes, causing IVF failure.
To improve fertility, the researchers targeted shugoshin1, a protein that keeps pairs of chromosomes glued together during egg development. Shugoshin1 levels decrease with age, weakening chromosomes' connection. The researchers experimented with restoring shugoshin1 to see if it would lessen defects.
Researchers microinjected shugoshin1 into mouse and donated human eggs. Microinjection resulted in a decrease in early chromosome separation. Human eggs experienced a decrease in chromosome defects from 53% to 29%. When looking specifically at eggs from women over 35, chromosome defects decreased from 65% to 44%. These findings suggest that protein injection repairs aged eggs by stabilising chromosome behaviour during division.
Currently, intracytoplasmic sperm injection (ICSI) is the only widely used microinjection method in fertility clinics. The researchers say the approach uses comparable techniques and are discussing possible clinical trials with regulators.
Commenting on the findings, Professor Guzel Taylor of the University of Edinburgh said the work was “a very promising result,” adding, “Since most women start IVF with already aged eggs, this technology is highly significant.”
Further studies are planned to assess safety and effectiveness before the method can be tested in clinical IVF settings
A new Ipsos survey commissioned by Fertility Matters Canada finds 49% of Canadians with an opinion support a national baseline for IVF funding support, with backing rising to 59% among those aged 18–34. One in eight Canadians say cost has already forced them or someone close to delay or abandon fertility treatment.
Alpha Controls & Instrumentation Inc. has been selected by FertiTech Canada Inc. as its third-party calibration partner for Nilotech temperature probes. The partnership channels Canadian IVF laboratories and fertility clinics using Nilotech equipment to Alpha Controls for professional, accredited calibration services, while FertiTech continues to handle equipment supply and gas sensor calibration.
In the UK, a Ten Minute Rule Bill has been introduced in the Commons to create a legal right to paid time off for fertility treatment, aiming to standardize access to time‑sensitive appointments and reduce reliance on employer discretion. The proposal seeks House permission to proceed and spotlights workplace rights during Fertility Awareness Week.
Columbia University Fertility Center has achieved the first confirmed pregnancy using an AI-guided sperm recovery method in a man with azoospermia, as detailed in The Lancet. The STAR system combined advanced imaging, microfluidics, and robotics to retrieve two viable sperm, enabling embryo creation after prior failed surgical and manual attempts.
British Columbia's free IVF program exhausts 2025 funding within months of launch. At least one approved clinic stops accepting new applications. Applicants face aging-out risks and must wait until spring 2026 for next funding allocation.
Singapore’s MOH approves 13 additional genetic conditions for testing before embryos are implanted during IVF, enhancing reproductive genetic screening options.
National Health Service-funded IVF in England varies across regions in terms of access, cycle definitions, and eligibility. While Integrated Care Boards follow NICE guidelines, local implementation differs to meet specific population needs. Current policy reviews aim to enhance consistency and ensure continued access to fertility services across England.
